The FDA drug recall system catches contamination issues before they reach patients

The Argatroban recall was issued before any adverse events were reported, but the presence of stainless steel in injectable drugs raises quality oversight questions.

Government and Regulatory Policy

CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.

2 debates·115 claims·181 news stories

Drug safety

Monitoring and prevention of adverse effects from medications.

46 claims·20 news stories

FDA regulation & drug policy

FDA oversight of drug approvals, drug scheduling, pharmaceutical tariffs, medical device regulation, and drug safety enforcement.

11 claims·25 news stories